- Presentation of interest revenue for certain financial instruments
- Accounting for fixed consideration in licence arrangements in the pharmaceutical and life sciences industry
- IASB revises the Conceptual Framework
- Disclosures required in interim financial statements on the initial adoption of IFRS 15
- IFRS 9 disclosures by banks in 2018 interim reporting and transition documents